Intravitreal vascular endothelial growth factor inhibitor systemic and renal toxicity registry

By afschroeder • August 5, 2025

Nguyen MD, Fekrat R, Gee C, Demirci AN, Kharabaf S, Le D, Tadros M, Nguyen VQ, Patel S, Truong T, Ahdoot R, Kurtz IB, Kerr M, Massoud A, Hanna R. Intravitreal vascular endothelial growth factor inhibitor systemic and renal toxicity registry. Clin Kidney J. 2025 Jun 27;18(8):sfaf206. doi: 10.1093/ckj/sfaf206. PMID: 40755970; PMCID: PMC12314269.

Tags: IVEGFi, Nephrology, nephrotic syndrome, nephrotoxicity, Publications, registry, thrombotic microangiopathy

Favorable Adherence and Tolerability of Letermovir Versus Valganciclovir for Cytomegalovirus Prophylaxis in Kidney Transplant Recipients Aged 65 y or Older: Findings From a Randomized, Phase 3 Trial

Bunnapradist S, Vincenti F, Witzke O, Schneeberger S, Nguyen MH, Broyde N, Gilbert CL, Haber B. Favorable Adherence and Tolerability of Letermovir Versus Valganciclovir for[...]

Online hemodiafiltration for kidney failure: guidance and best clinical practice recommendations from the Italian Society of Nephrology

Strippoli GFM, Pellegrino G, Hegbrant J, Fabbrini P, Lentini PLM, Aucella F, Panichi V, Gallieni M, Canaud B, Davenport A, Ortiz A, Ramos R, Malyszko[...]

A literature review and reflection on clinical trials: current challenges, future directions, and potential strategies to overcome practical barriers

Zhang K, Lampridis S, Simone CB 2nd, Negoi I, Peng Y, Shang B, Lin Y, Cheng Y, Yang F, Shelat VG, Kalantar-Zadeh K. A literature[...]